The effects of COVID‐19 on IBD prescribing and service provision in a UK tertiary centre

Author:

Sharma Esha1ORCID,Meade Susanna1ORCID,D’Errico Francesca1,Pavlidis Polychronis12,Luber Raphael1,Zeki Sebastian1,Hill Katie1,Duff Alexa1,O’Hanlon Dearbhaile1,Tripoli Sherill1,Stanton Anna1,Caracostea Andra1,Honap Sailish1,Reynolds Rebecca1,Anderson Simon1,Ray Shuvra1,Mawdsley Joel1,Sanderson Jeremy1,Samaan Mark A.1,Irving Peter M.12ORCID

Affiliation:

1. Inflammatory Bowel Disease Unit Guy’s and St Thomas’ Hospital London UK

2. School of Immunology and Microbial Sciences King’s College London London UK

Publisher

Hindawi Limited

Reference31 articles.

1. Advice for Endoscopy Teams during COVID‐19;Endoscopy JAGoG;BSG,2020

2. British Society of Gastroenterology.BSG guide for IBD patients during COVID‐19 pandemic.2020.

3. Infliximab and adalimumab for the treatment of Crohn's disease;National Institute for Health and Care Excellence;NICE,2010

4. Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis

5. Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3